Pharmacogenetics of oral anticoagulants

Abstract excerpt

There is wide interindividual variation in oral anticoagulant dose requirement, which is partly genetically determined. Several cytochrome P450s contribute to oxidative metabolism of oral anticoagulants. The most important of these is CYP2C9, which hydroxylates the S-enantiomers of warfarin, acenocoumarol and phenprocoumon with high catalytic activity. In at least eight separate clinical studies, possession of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Eicosanoids and Hypertension Pharmacology
• Share to Hormonal Regulation and Hypertension
• Share to Pharmacogenetics and Drug Metabolism